News und Analysen
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Evotec and Related Sciences expand integrated drug discovery and development partnership
LivaNova leitet die begrenzte Markteinführung des Essenz Perfusion System für kardiopulmonale Bypassverfahren in Europa ein
LivaNova PLC (Nasdaq: LIVN), ein marktführendes Unternehmen im Bereich Medizintechnik und Innovation, hat heute den Beginn einer begrenzten kommerziellen Freigabe für das Essenz™ Perfusion System*
EQS-Adhoc: Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
EQS-Adhoc: Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release has
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Bronson Healthcare and Acadia Healthcare Name Deb Rozewicz As CEO of Bronson Behavioral Health Hospital
Bronson Healthcare and Acadia Healthcare Company have named Deb Rozewicz, RN, as chief executive officer for Bronson Behavioral Health Hospital, the 96-bed inpatient behavioral health hospital
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today unveiled the company’s second Super Bowl commercial, which announces the US
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today unveiled the company’s second Super Bowl commercial, which announces the US
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
LivaNova Launches SenTiva DUO
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today launched SenTiva DUO™, an implantable pulse generator (IPG) with a dual-pin header to provide VNS
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Evotec announces agreement with Janssen to develop immune-based therapies
New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management
Waters Corporation (NYSE:WAT) today announced waters_connect™ System Monitoring, a new Software-as-a-Service (SaaS) application that enables laboratory managers and analysts to monitor the
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc